![David Dellamonica: Thrilled to be part of ESMO2024](https://oncodaily.com/pub/uploads/2024/09/dav.jpg)
David Dellamonica: Thrilled to be part of ESMO2024
David Dellamonica shared a post on LinkedIn:
“Our team is thrilled to be part of ESMO2024 in Barcelona from September 13-17, where we will explore how innovative technologies have the potential to shape the future of cancer care.
From real-world data utilization in precision oncology to AI-based tools for targeting treatment and responses, I’m excited to see how digital will continue to drive impact across the care pathway!
Stay tuned for our insights and key takeaways from these sessions!”
Source: David Dellamonica/LinkedIn
David Dellamonica is the Global Head of Precision Digital Healthcare at AstraZeneca. He leads the Precision Digital Health Delivery team, driving initiatives across all AstraZeneca business units and implementing digital solutions throughout the care pathway.
He has authored publications on AI, oncology, cardio-metabolic care pathways, and value-based partnerships. Dellamonica also actively contributes to discussions on the European Commission’s Data Strategy and AI White Paper.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023